Luye Claims A First With Chinese Denosumab Approval

Boan Biotech Subsidiary Sees Prolia Biosimilar Boyoubei Approved By China’s NMPA

 
• By David Wallace
  
Prolia pack injector
Luye’s biosimilar version of Prolia has been approved in China • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products